KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Neogenomics (NEO) Shares Outstanding (Diluted Average) (2016 - 2025)

Historic Shares Outstanding (Diluted Average) for Neogenomics (NEO) over the last 16 years, with Q3 2025 value amounting to $128.4 million.

  • Neogenomics' Shares Outstanding (Diluted Average) rose 115.16% to $128.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $128.4 million, marking a year-over-year increase of 115.16%. This contributed to the annual value of $126.7 million for FY2024, which is 92.11% up from last year.
  • According to the latest figures from Q3 2025, Neogenomics' Shares Outstanding (Diluted Average) is $128.4 million, which was up 115.16% from $127.9 million recorded in Q2 2025.
  • Neogenomics' Shares Outstanding (Diluted Average)'s 5-year high stood at $131.2 million during Q2 2021, with a 5-year trough of $116.2 million in Q1 2021.
  • Its 5-year average for Shares Outstanding (Diluted Average) is $125.1 million, with a median of $125.5 million in 2023.
  • Its Shares Outstanding (Diluted Average) has fluctuated over the past 5 years, first soared by 2164.3% in 2021, then plummeted by 546.26% in 2022.
  • Over the past 5 years, Neogenomics' Shares Outstanding (Diluted Average) (Quarter) stood at $120.0 million in 2021, then increased by 3.55% to $124.2 million in 2022, then grew by 1.03% to $125.5 million in 2023, then grew by 0.92% to $126.7 million in 2024, then grew by 1.39% to $128.4 million in 2025.
  • Its Shares Outstanding (Diluted Average) stands at $128.4 million for Q3 2025, versus $127.9 million for Q2 2025 and $127.4 million for Q1 2025.